1. Home
  2. JSPR vs PNI Comparison

JSPR vs PNI Comparison

Compare JSPR & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPR
  • PNI
  • Stock Information
  • Founded
  • JSPR 2018
  • PNI 2002
  • Country
  • JSPR United States
  • PNI United States
  • Employees
  • JSPR N/A
  • PNI N/A
  • Industry
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • PNI Trusts Except Educational Religious and Charitable
  • Sector
  • JSPR Health Care
  • PNI Finance
  • Exchange
  • JSPR Nasdaq
  • PNI Nasdaq
  • Market Cap
  • JSPR 68.4M
  • PNI 78.4M
  • IPO Year
  • JSPR N/A
  • PNI N/A
  • Fundamental
  • Price
  • JSPR $1.79
  • PNI $7.00
  • Analyst Decision
  • JSPR Buy
  • PNI
  • Analyst Count
  • JSPR 12
  • PNI 0
  • Target Price
  • JSPR $25.60
  • PNI N/A
  • AVG Volume (30 Days)
  • JSPR 402.4K
  • PNI 26.4K
  • Earning Date
  • JSPR 11-10-2025
  • PNI 01-01-0001
  • Dividend Yield
  • JSPR N/A
  • PNI 4.76%
  • EPS Growth
  • JSPR N/A
  • PNI N/A
  • EPS
  • JSPR N/A
  • PNI N/A
  • Revenue
  • JSPR N/A
  • PNI N/A
  • Revenue This Year
  • JSPR N/A
  • PNI N/A
  • Revenue Next Year
  • JSPR N/A
  • PNI N/A
  • P/E Ratio
  • JSPR N/A
  • PNI N/A
  • Revenue Growth
  • JSPR N/A
  • PNI N/A
  • 52 Week Low
  • JSPR $1.60
  • PNI $6.03
  • 52 Week High
  • JSPR $26.05
  • PNI $7.89
  • Technical
  • Relative Strength Index (RSI)
  • JSPR 33.13
  • PNI 56.67
  • Support Level
  • JSPR $1.61
  • PNI $6.93
  • Resistance Level
  • JSPR $1.98
  • PNI $7.07
  • Average True Range (ATR)
  • JSPR 0.18
  • PNI 0.05
  • MACD
  • JSPR -0.04
  • PNI -0.01
  • Stochastic Oscillator
  • JSPR 18.84
  • PNI 66.67

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About PNI Pimco New York Municipal Income Fund II of Beneficial Interest

PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

Share on Social Networks: